Dihexa
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)
A potent nootropic peptide analog of angiotensin IV with exceptional cognitive-enhancing and neurogenic properties. Seven orders of magnitude more potent than BDNF.
Typical Cost
$100-200/vial (10mg)
Status
Research
Peptide Profile
Dihexa
Mechanism of Action
Potent activator of hepatocyte growth factor (HGF) with exceptional affinity for HGF receptors. Promotes synaptogenesis, neurogenesis, and enhances cognitive function far beyond other nootropics.
Common Dosages
subcutaneous
8-20mcg
Daily · 4-8 weeks
Benefits
Extreme potency
Neurogenesis
Synaptogenesis
Cognitive enhancement
Memory improvement
Side Effects
Limited human data
Potentially too powerful
Unknown long-term effects
High risk experimental
Key Research
Dihexa HGF activation
Demonstrated 7 orders of magnitude greater potency than BDNF for synaptogenesis
Dihexa Alzheimer's potential
Reversed cognitive deficits in Alzheimer's animal models
Regulatory Status
Research chemical only. Not FDA-approved. Extremely potent experimental nootropic.
Contraindications
- ⚠All populations - extremely experimental
- ⚠Pregnancy/breastfeeding
- ⚠Cancer concerns
Not appropriate for general use. SeraVia formulations offer safer cognitive support.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.